Objective:

To summarize the advocacy efforts and outcomes related to ASC reimbursement changes for 2026, highlighting their significance.

Approach:

Key Findings:

• CMS granted an 8.4% increase in facility fees for cataract surgery (CPT 66984) for 2026, addressing previous proposed reductions.
• ASC payment rates will increase by 2.6%, based on the hospital market basket index, reflecting ongoing advocacy efforts.
• Several outdated ASC quality measures will no longer be required, reducing administrative burdens.
• Mandatory prior authorization for certain procedures has been delayed, though concerns remain about future implementation.

Interpretation:

The advocacy efforts of the ophthalmic ASC community have led to significant improvements in reimbursement rates and reduced administrative burdens, setting a precedent for future advocacy.

Limitations:

• Ongoing challenges remain regarding ASC payments and prior authorization processes, which could impact future reimbursement.
• Potential administrative burdens from the prior authorization demonstration project may complicate operations for ASCs.

Conclusion:

Continued advocacy is essential for maintaining and improving ASC reimbursement and regulatory conditions, emphasizing the need for strategic actions moving forward.

Sources:

• OOSS
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.